2C3D

Revolutionizing Skin Tumor Resection

Health Tech & Life Sciences
Active
Pre-Funding Founded 2023
Total raised
$40K
Stage
Pre-Funding
Founded
2023
Headcount
5
HQ
Sector
Health Tech & Life Sciences

About

The company is at the forefront of advancing melanoma cancer treatment by integrating state-of-the-art diagnostic methods and digital pathology. Its unique approach is aimed at achieving complete eradication of melanoma through a singular surgical procedure. By studying the functional properties of melanoma, the company aims to enhance treatment outcomes and potentially expand these methods to other types of skin tumors. Committed to advancing medical knowledge, the company is dedicated to reshaping the landscape of skin cancer treatment and making a lasting impact on patients' lives.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was 2C3D founded?
2C3D was founded in June 2023.
What is 2C3D's primary focus in healthcare?
2C3D focuses on advancing melanoma cancer treatment by integrating diagnostic methods and digital pathology to achieve complete eradication through a single surgical procedure.
What was 2C3D's former name?
2C3D was formerly known as Skin Sight.
How many employees does 2C3D currently have?
2C3D currently has 5 employees.
What is 2C3D's current funding stage?
2C3D is currently in the Pre-Funding stage.
Has 2C3D received any grants?
In October 2023, 2C3D received a grant of $40,000 from the IIA.
What is the total amount of funding 2C3D has raised?
2C3D has raised a total of $40,000, primarily from grants. For a full financing history, please refer to startupim.
Who are the founders of 2C3D?
The founders of 2C3D are Or Litman and Lior Saban.
What technologies does 2C3D utilize in its operations?
2C3D utilizes Artificial Intelligence in its operations.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcarePatients
Business model
B2B2CB2B

Tags

cancercancer-research